Pharmafile Logo

Speak First

Speak First is all about three things – confidence, impact and clarity. Our communication skills training and coaching is guaranteed to enhance business relationships. With over 20 years’ experience, we are global specialists in soft skills training essential for business success. Our expertise include: presentation skills, personal impact, media training, selling and negotiation skills, business writing, NLP for Business and other interpersonal and communication skills training to improve workplace effectiveness and career success.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

1st Floor, 20 Old Street, London, EC1V 9AB, United Kingdom
+44 (0)20 7253 2117

 Latest Content from PMHub 

Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions

Press Releases | February 14, 2024 | Petauri Evidence

Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.

The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid

Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...

Product launch: What market research when?

White Papers and Resources | February 14, 2024 | Inizio

Get the insights you need, when you need them, for your product launch planning

Clinical trial considerations: Why digital matters…

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Top-5 Trends in Virtual KOL Engagement

Press Releases | February 12, 2024 | Impetus Digital

Register now for one of our upcoming webinars (February 26-28)

Therapy Watch launches new tracker covering Alzheimer’s Disease

White Papers and Resources | February 12, 2024 | Inizio

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

Medscape Education Leads the Industry into New Era of Precision Education with Guaranteed Impact

Press Releases | February 9, 2024 | Medscape Education

NEWARK, N.J., Feb. 8, 2024 /PRNewswire/ -- Medscape Education has just unveiled its pioneering approach to developing and delivering medical education designed to drive guaranteed reach, precision targeting, and impact during this...

Imagine More for the reporting of consensus programme outputs

Press Releases | February 9, 2024 | Resonant Group

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

White Papers and Resources | February 9, 2024 | Inizio

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.